Review

  • HOME
  • ARTICLE CATEGORY
  • Review
Review
2093
Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
Atsumasa Komori, Yuki Kugiyama
Clin Mol Hepatol. 2025;31(1):90-104.   Published online November 11, 2024
View: 1005   Download: 177
2076
Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations
Pojsakorn Danpanichkul, Kanokphong Suparan, Vitchapong Prasitsumrit, Aijaz Ahmed, Karn Wijarnpreecha, Donghee Kim
Clin Mol Hepatol. 2025;31(1):74-89.   Published online October 23, 2024
View: 2181   Download: 318  Web of Science: 4  Crossref: 6
2073
Bioactive metabolites: A clue to the link between MASLD and CKD?
Wen-Ying Chen, Jia-Hui Zhang, Li-Li Chen, Christopher D. Byrne, Giovanni Targher, Liang Luo, Yan Ni, Ming-Hua Zheng, Dan-Qin Sun
Clin Mol Hepatol. 2025;31(1):56-73.   Published online October 21, 2024
View: 1335   Download: 163
2050
Sinusoidal communication in chronic liver disease
Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho
Clin Mol Hepatol. 2025;31(1):32-55.   Published online October 2, 2024
View: 1202   Download: 202
2048
Roles of X-box binding protein 1 in liver pathogenesis
Jihoon Tak, Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol. 2025;31(1):1-31.   Published online October 2, 2024
View: 1537   Download: 150
1967
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
Clin Mol Hepatol. 2024;30(4):620-648.   Published online July 11, 2024
View: 3265   Download: 254  Web of Science: 5  Crossref: 5
1955
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
Clin Mol Hepatol. 2024;30(4):585-619.   Published online July 1, 2024
View: 2994   Download: 294  Web of Science: 1  Crossref: 1
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Clin Mol Hepatol. 2024;30(3):326-344.   Published online April 26, 2024
View: 3265   Download: 163  Web of Science: 5  Crossref: 2
1896
Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
Clin Mol Hepatol. 2024;30(3):303-325.   Published online February 28, 2024
View: 5228   Download: 315  Web of Science: 5  Crossref: 9
1875
Comprehensive approach to controlling chronic hepatitis B in China
Shan Shan, Xinyan Zhao, Jidong Jia
Clin Mol Hepatol. 2024;30(2):135-143.   Published online January 5, 2024
View: 4326   Download: 246  Web of Science: 2  Crossref: 2
1858
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu
Clin Mol Hepatol. 2024;30(1):16-36.   Published online October 4, 2023
View: 5974   Download: 329  Web of Science: 10  Crossref: 10
1842
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):1-15.   Published online July 21, 2023
View: 8471   Download: 424  Web of Science: 28  Crossref: 28
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Sung Uk Lee, Tae Hyun Kim
Clin Mol Hepatol. 2023;29(4):958-968.   Published online August 29, 2023
View: 3754   Download: 113  Web of Science: 5  Crossref: 5
1844
Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
Hwa Kyung Byun, Changhwan Kim, Jinsil Seong
Clin Mol Hepatol. 2023;29(4):945-957.   Published online August 14, 2023
View: 3498   Download: 112  Web of Science: 8  Crossref: 9
1835
Evidence-based hyponatremia management in liver disease
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Clin Mol Hepatol. 2023;29(4):924-944.   Published online June 5, 2023
View: 4900   Download: 295  Web of Science: 6  Crossref: 6
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
Landon L. Chan, Stephen L. Chan
Clin Mol Hepatol. 2023;29(4):909-923.   Published online May 25, 2023
View: 3862   Download: 268  Web of Science: 11  Crossref: 12
1816
Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung, Jai Won Chang
Clin Mol Hepatol. 2023;29(4):891-908.   Published online April 13, 2023
View: 9002   Download: 1,316  Web of Science: 7  Crossref: 8
1798
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(4):869-890.   Published online March 14, 2023
View: 4415   Download: 222  Web of Science: 8  Crossref: 12
1791
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clin Mol Hepatol. 2023;29(4):851-868.   Published online March 9, 2023
View: 9086   Download: 432  Web of Science: 18  Crossref: 16
Special Review
1854
Waiting for the changes after the adoption of steatotic liver disease
Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(4):844-850.   Published online September 6, 2023
View: 3428   Download: 181  Web of Science: 20  Crossref: 27
1849
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi-Ae Kim, Joon Ho Moon, Won Kim
Clin Mol Hepatol. 2023;29(4):831-843.   Published online August 25, 2023
View: 5861   Download: 392  Web of Science: 45  Crossref: 50
Review
1807
Acute-on-chronic liver failure: Terminology, mechanisms and management
Vinay Kumar BR, Shiv Kumar Sarin
Clin Mol Hepatol. 2023;29(3):670-689.   Published online March 20, 2023
View: 8322   Download: 834  Web of Science: 18  Crossref: 21
1788
A decade of liver organoids: Advances in disease modeling
Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan
Clin Mol Hepatol. 2023;29(3):643-669.   Published online March 6, 2023
View: 10305   Download: 327  Web of Science: 8  Crossref: 8
1781
Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):623-642.   Published online February 20, 2023
View: 7337   Download: 463  Web of Science: 21  Crossref: 23
1775
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):605-622.   Published online February 15, 2023
View: 6020   Download: 334  Web of Science: 24  Crossref: 29
1774
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Clin Mol Hepatol. 2023;29(3):593-604.   Published online February 13, 2023
View: 5832   Download: 375  Web of Science: 20  Crossref: 19
1770
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331.   Published online February 1, 2023
View: 7569   Download: 458  Web of Science: 30  Crossref: 38
1769
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
Clin Mol Hepatol. 2023;29(2):293-319.   Published online February 1, 2023
View: 5377   Download: 125  Web of Science: 9  Crossref: 9
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
Clin Mol Hepatol. 2023;29(2):277-292.   Published online January 30, 2023
View: 9206   Download: 599  Web of Science: 44  Crossref: 47
1764
The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(2):263-276.   Published online January 19, 2023
View: 6431   Download: 338  Web of Science: 16  Crossref: 15

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 44
TOTAL : 2442191
Close layer